다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

GOSS

Gossamer Bio (GOSS)

Gossamer Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GOSS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/13	06:40	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:GOSS	Gossamer Bio Inc
2024/11/12	06:01	Business Wire	Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GOSS	Gossamer Bio Inc
2024/11/08	06:03	Business Wire	Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:GOSS	Gossamer Bio Inc
2024/11/08	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/11/08	06:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GOSS	Gossamer Bio Inc
2024/10/08	06:01	Business Wire	Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GOSS	Gossamer Bio Inc
2024/09/14	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/08/27	05:01	Business Wire	Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024	NASDAQ:GOSS	Gossamer Bio Inc
2024/08/13	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/08/13	05:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GOSS	Gossamer Bio Inc
2024/08/13	05:01	Business Wire	Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:GOSS	Gossamer Bio Inc
2024/08/03	07:30	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:GOSS	Gossamer Bio Inc
2024/07/19	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/06/11	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/06/08	05:30	Business Wire	Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GOSS	Gossamer Bio Inc
2024/06/07	10:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/15	05:01	Business Wire	Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/11	05:30	Business Wire	Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/08	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/08	05:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/08	05:01	Business Wire	Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/06	20:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/06	20:30	Business Wire	Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/03	21:02	Business Wire	Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/12	20:31	Business Wire	Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/05	21:37	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/05	21:32	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/05	21:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/05	21:31	Business Wire	Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update	NASDAQ:GOSS	Gossamer Bio Inc
2024/03/05	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc

검색 관련기사 보기:NASDAQ:GOSS

1 2 3 4 5 6 7 8 9 10 다음 >>

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관